scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.HYP.0000153461.58298.A4 |
P698 | PubMed publication ID | 15630046 |
P50 | author | Maureen Macleod | Q39658662 |
Jenny Myers | Q47504187 | ||
P2093 | author name string | Philip Baker | |
Gary Mires | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pre-eclampsia | Q61335 |
P304 | page(s) | 258-263 | |
P577 | publication date | 2005-02-01 | |
P1433 | published in | Hypertension | Q5958695 |
P1476 | title | In Preeclampsia, the Circulating Factors Capable of Altering In Vitro Endothelial Function Precede Clinical Disease | |
P478 | volume | 45 |
Q27003730 | A brief overview of preeclampsia |
Q33515798 | A gel-free quantitative proteomics analysis of factors released from hypoxic-conditioned placentae |
Q55379353 | Antidepressant use during pregnancy and the risk of developing gestational hypertension: a retrospective cohort study. |
Q83427587 | Association between matrix metalloproteinase (MMP)-2 polymorphisms and MMP-2 levels in hypertensive disorders of pregnancy |
Q33825219 | Effects of maternal serum on permeability of glomerular endothelial cell membrane |
Q37229246 | Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia |
Q56970549 | EndothelialFOSexpression and pre-eclampsia |
Q35581520 | IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate? |
Q39675205 | Low maternal middle cerebral artery Doppler resistance indices can predict future development of pre-eclampsia |
Q36910638 | Matrix metalloproteinases as drug targets in preeclampsia |
Q89763980 | Mechanisms linking exposure to preeclampsia in utero and the risk for cardiovascular disease |
Q39816316 | Plasma from women with preeclampsia inhibits trophoblast invasion. |
Q36682012 | Polymorphisms of the IL27 gene in a Chinese Han population complicated with pre-eclampsia |
Q56019568 | Pre-eclampsia |
Q35143007 | Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease |
Q47963729 | Preeclamptic toxemia: a disease ripe for proteomic discovery |
Q36633983 | Pregnancy as the prodrome to vascular dysfunction and cardiovascular risk |
Q37079628 | Recent progress toward the understanding of the pathophysiology of hypertension during preeclampsia |
Q33729040 | Resistance artery adaptation to pregnancy counteracts the vasoconstricting influence of plasma from normal pregnant women |
Q92179614 | Resveratrol improves endothelial cell markers impaired by plasma incubation from women who subsequently develop preeclampsia |
Q33666195 | Study of Nitrosative Stress in 'Pregnancy Induced Hypertension'. |
Q52631138 | The expression and function of KCNQ potassium channels in human chorionic plate arteries from women with normal pregnancies and pre-eclampsia. |
Q37088970 | The role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsia |
Q38124456 | Vascular dysfunction in preeclampsia |